Pediatric cancer recurrence is a significant concern for families dealing with childhood malignancies, particularly brain tumors such as gliomas.A groundbreaking study conducted at Mass General Brigham reveals that an innovative AI tool can predict the risk of disease relapse with remarkable accuracy, surpassing traditional diagnostic methods.